Oncologists Market Scope, Share Analysis And Growth 2025

Crafted for informed planning, this report explores the forces reshaping the oncologists market and what they mean for business leaders.

How Big Is The Oncologists Market In 2025?
The oncologists market size has grown marginally in recent years. It will grow from $19.93 billion in 2024 to $20.21 billion in 2025 at a compound annual growth rate (CAGR) of 1.4%. The growth in the historic period can be attributed to increasing cancer incidence, therapeutic advancements, aging population, healthcare infrastructure development, awareness and early detection programs.

The oncologists market size is expected to see steady growth in the next few years. It will grow to $23.99 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, emerging therapeutic modalities, global oncology collaboration, epidemiological shifts and new challenges, healthcare policy and economic factors. Major trends in the forecast period include immunotherapy advancements, precision medicine integration, telemedicine expansion, data-driven decision-making, collaborative care models, and patient-centric care.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9474&type=smp

What Are The Major Factors Driving The Oncologists Global Market Growth?
The growing prevalence of cancer is expected to propel the oncologists market going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. The prevalence of cancer refers to the number of new cancer cases that arise in a specified population in a given period of time. Oncologists refer to healthcare practitioners who are specialized in the diagnosis and treatment of cancer. They are involved in examining the patient, diagnosing the cancer, and identifying treatment options. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, there were about 18.1 million cancer survivors in the United States. This figure is projected to rise to 22.5 million by 2032. By 2040, it's expected that the number of new cancer cases each year will reach 29.9 million, with cancer-related deaths estimated to increase to 15.3 million. Therefore, the growing prevalence of cancer is driving the oncologists market.

Oncologists Market Report Segmentation Analysis
The oncologistsmarket covered in this report is segmented –

1) By Cancer Diagnostics And Treatment: Cancer Diagnostics; Cancer Treatment
2) By Indication: Lungs Cancer; Colorectal Cancer; Breast Cancer; Liver Cancer; Bladder Cancer; Head And Neck Cancer; Prostate Cancer; Other Indications
3) By End Use: Hospitals; Diagnostic Laboratories; Diagnostic Imaging Centers; Specialty Clinics; Academia; Other End Uses

Subsegments:
1) By Cancer Diagnostics: Imaging Tests; Biopsy; Blood Tests; Molecular Diagnostics; Genetic Testing
2) By Cancer Treatment: Chemotherapy; Radiation Therapy; Immunotherapy; Targeted Therapy; Hormone Therapy; Stem Cell Transplant

What Are The Main Trends, Positively Impacting The Growth Of Oncologists Market?
Major companies operating in the oncologists market are focused on introducing AI-precision oncology centers to enhance personalized cancer treatment, improve diagnostic accuracy, and optimize treatment plans based on individual patient data and tumor characteristics. AI-precision oncology centers refer to specialized medical facilities that utilize artificial intelligence (AI) and machine learning technologies to provide highly personalized cancer care. For instance, in January 2024, Apollo Cancer Centre, an India-based hospital, launched Apollo Cancer Centre. The center will assist oncologists, patients, and caregivers in achieving the best possible outcomes within a defined timeframe by leveraging the vast potential of AI technology. The POC utilizes AI technologies to provide precise diagnoses and real-time insights into patient conditions. This capability allows for timely interventions and better management of cancer cases. The centre conducts comprehensive cancer risk assessments, helping to identify patients who may benefit from targeted therapies or immunotherapy as part of their treatment plans.

What Are The Top Players Operating In The Oncologists Market?
Major companies operating in the oncologists market include Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité - Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

View the full oncologists market report here:
https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Which Region Holds The Largest Market Share In The Oncologists Market?
North America was the largest region in the oncologists market in 2024. The regions covered in the oncologists market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company